ASBMT Pharmacy Special Interest Group (SIG) Update 2014 2015 Jamie F - - PDF document

1/21/2015 1

ASBMT Pharmacy Special Interest Group (SIG) Update 2014‐2015

Jamie F Shapiro, Pharm.D, BCOP Clinical Pharmacy Coordinator, Stem Cell Transplant Chair, ASBMT Pharmacy SIG February 13, 2015

Disclosures

• I have no relevant disclosures

Objectives

• Review the current initiatives of the Working

Committees

• Outline achievements accomplished by

Pharmacy SIG Steering Committee and Working Committees

• Discuss future directions for the Pharmacy SIG

Working Committees

1/21/2015 2 ASBMT Pharmacy SIG Audience Response Question # 1

Which of the following statements is true? a) In order to become a working committee member of

the ASBMT Pharmacy SIG, you have to be a SIG member b) There is a small fee if you are an ASBMT member to become a member of the Pharmacy SIG c) Members of the Pharmacy SIG have many responsibilities, calls, and tasks throughout the year d) The applications for working committees are accepted twice a year

SIG Structure and Function

Steering Committee

Education Research Advocacy and Policy Communications (Website) Program Planning Membership

Membership

• February 2014 – 99 members
• September 30, 2014 – 131 members (32%

increase)

• Continued Recruitment Initiatives
• Booth exchange with HOPA at annual meeting
• Maintenance of membership database
• Letters to PGY2 directors highlighting benefits of

membership including:

— Reduced membership fee for residents in training — Networking — Opportunities for leadership

1/21/2015 3 Membership

• New Initiatives and Roles
• Awards

— Selection of recipients for Lifetime Achievement Award and New Practitioner Award

• Shared advertising with International Society of

Oncology Pharmacy Practitioners (ISOPP) website

• Defined “Role of HCT Pharmacists” on ASBMT

Pharmacy SIG website

Membership: Future Initiatives

• Letter to BMT directors about new FACT CE

requirements for Pharm.D

• Awards
• Expansion of awards offered: research or literature

award

• Develop novel methods for recruitment
• Increase membership by 25%
• Initiate collaboration with Schools of Pharmacy
• Developing survey to send out to schools to identify

and assess needs for HCT lecture

Communications: Accomplishments

• 3 newsletters published
• Maintains and updates content for ASBMT Pharmacy

SIG website

1/21/2015 4 Communications: New Initiatives

• Guidelines established for contributors and

reviewers of newsletter for:

• Developing educational content
• Article selection and review
• Literature email updates sent out monthly
• Promotion of Clinical Case Forum

Clinical Case Forum

• Multidisciplinary case‐based forum for

addressing clinical conundrums in practice

• Collaborate with other Pharm.D, MD, APP,

nursing regarding complex cases

• Over 4000 users across globe
• Pharmacy Group developed our own section

within site

Communications: Future Goals

• Expansion of educational materials housed on

website and in newsletter with Education Committee

• Develop relationship with student organizations

and residency programs highlighting HCT pharmacy as profession

• Open lines of communication with other

pharmacy organizations to improve collaborative practice

1/21/2015 5 Program Planning

• Continued and Future initiatives
• Execute quality educational program for HCT

Pharmacists

• Continue to utilize technology to enhance

experience of audience

• Collaborate with multi‐disciplinary SIG to order to

develop programming for larger audience

• Offer additional professional networking at

conference

• Evaluate opportunities for Pharmacy SIG sponsored

symposium at BMT Tandem Meeting

Advocacy and Policy

• Updates SIG members about current events

affecting HCT Pharmacy population

• Board of Pharmacy Specialties (BPS) solicited

feedback regarding BPS Pharmacy Specialty Structure and Framework paper

— BCOP would obtain subspecialty designation for HCT

• Addressed BPS paper by developing survey to assess

HCT pharmacists and their views on subspecialty creation and added qualifications (AQ) to represent HCT community

— 81 responded (45 for subspecialty, 36 against)

Advocacy and Policy: Response to BPS

• Pharmacy SIG commented:
• Subspecialty will recognize that practicing in HCT does

require additional knowledge and practice beyond BCOP

• Subspecialty designation would not likely create new job
• pportunities, justify more full‐time employees, increase

compensation

• Respondents would rather earn more CE vs. taking exam
• Would consider AQ if subspecialty not adopted

1/21/2015 6 Advocacy and Policy: Response to BPS

• Questions posed to BPS:
• How will CE opportunities be provided and

regulated for the subspecialty?

• How will earning subspecialty designation lend to

increased opportunities for pharmacists?

• Very well received by BPS

Advocacy and Policy: Accomplishments and Future Projects

• Poster 5644: “Results of the ASBMT Pharmacy

SIG Practice Survey – Understanding Today to Meet the Needs of Tomorrow”

• Recognition letters for Working Committee

Members

• Advocacy 101 Guide
• Develop mentoring program

Education

Current Initiatives

• Fundamentals of HCT 2014
• 74 attendees (34% increase)
• Next Fundamentals will be in Austin, TX

following HOPA meeting, March 28‐29, 2015

• 8 hours CE
• Flash drive with ALL course materials for attendees

(plus available for purchase for those not able to attend meeting)

• Open to all disciplines, ACPE, nursing CE
• $245 registration

1/21/2015 7 Education: Fundamentals Course

Topic Speaker

Introduction to Transplant Susannah Koontz Mobilization Aimee Hammerstrom Preparative Regimens Cathryn Jennisen Complications of Transplant Alex Ganetsky Fungal and Viral Infections Kristen Held Bacterial Infections Aimee Hammerstrom GVHD‐ Acute Susie Liewer GVHD‐Chronic Ryan Bookout BMT Pharmacy Practice Models Michael Westmoreland Melisa Stricherz Kamakshi Rao

Education: Upcoming Events

• Online case series housed on Pharmacy SIG webpage

associated with lectures given at BMT Pharmacists Conference at the BMT Tandem Meetings

• Intend to provide ACPE in future
• Future initiatives
• Work with communications committee to utilize ASBMT

Pharmacy SIG Website to post educational resources and standards of care guidelines

• Provide programming/ACPE for advanced practitioners
• Work with NMDP System Capacity Initiative Group to support

need for educational opportunities

• Develop ASBMT Guidelines in collaboration with physicians

Research

• Reviewed abstracts submitted to pharmacy

category for the BMT Tandem Meeting and selected 4 top abstracted to be presented

• 21 abstracts submitted
• Busulfan pharmacokinetic protocol being

submitted through multiple IRBs

• Development of policy for conducting research

within ASBMT Pharmacy SIG with intention to publish

1/21/2015 8 Research Policy

• Purpose: to recognize individuals collaborating

with projects, i.e. responses to surveys and list serv questions

• Requires proposal submitted to chair of

Research Working committee

• Policy does not apply to surveys/questions asked

for purposes of application for clinical practice

• nly, as long as material is not shared as

presentation/publication

Research: Future Initiatives

• Identify ways to encourage and support

pharmacist led research in HCT

• Evaluate funding opportunities for research with

Pharmacy SIG

• Collaborate on research protocols
• Consider a research “boot camp” at Tandem

meeting

Steering Committee

• Selection of working committee members
• Maintains and updates charters and policy and

procedures

• Oversees all activities of Working Committees
• Provides guidance on new initiatives and policies
• Submits proposals to ASBMT Executive

Committee (EC) as needed

• Provides communication between ASBMT EC

and working committees

• Responds to HCT related pharmacy issues

1/21/2015 9 Steering Committee: Responds to CMS Part D Immunosuppressants

• CMS proposed to remove immunosuppressants

from list of drugs in protected class as part of Part D formulary

• NMDP asked for Steering committee assistance

in drafting letter to CMS

• Letter discussed importance of availability of

immunosuppressants and that they are not interchangable

ASBMT Pharmacy SIG Audience Response Question # 2

The revised FACT/JACIE Standards 6th edition states that pharmacists are now required to

• btain how many hours of continuing education.

a.) 20 b.) 10 c.) 0 d.) 5

1/21/2015 10

Foundation for the Accreditation of Cellular Therapy (FACT) 6th edition

• NMDP System Capacity Initiative (SCI)
• Strengthen role of Pharm.D as part of

multidisciplinary team and include essential roles and responsibilities

— Training includes: overview of cellular process, therapeutic drug monitoring, adjustments of drugs for

• rgan dysfunction

— Pharmacists should be involved in development of guidelines/standard operating procedures (SOP)

• Steering Committee asked to provide feedback
• n proposed Standards

FACT 6th edition

• New requirements for APP, Pharm.D, Nursing
• Include 10 hours of educational activities related to

cellular therapy annually

— Can include attending conferences, institutional grand rounds, reviewing journal articles…. — Key will be to maintaining documentation

• Title of activity, type of activity (webinar, meeting,

grand round), topic of activity, date of activity, approximate number of hours

• Responsibility of clinical program to inform staff

about FACT standards changes

• New guidelines to be released March 2015

FACT 6th edition: Looking Ahead

• Discussion to participate in webinar defining role
• f Pharm.D in HCT with collaboration from FACT

and NMDP

1/21/2015 11 Pharmacy SIG Steering Committee 2015‐2016

• Tippu Khan, Chair
• Alison Gulbis, Chair‐Elect
• Jamie Shapiro, Past‐Chair
• Kelly Hawks
• Julie Merten
• Susie Liewer
• Joseph Bubalo*

* Newest member voted in at ASBMT board meeting

ASBMT Pharmacy SIG Working Committees 2014‐2015

Steering

• Jamie Shapiro, Chair
• Tippu Khan, Chair‐elect
• Tracey Walsh Chocolaad,

Past Chair

• Alison Gulbis
• Kelly Hawks
• Susie Liewer
• Julie Merten

Program Planning

• Amber Lawson, Chair
• Kelly Hawks, Chair‐elect
• Alison Gulbis, Past Chair
• Jayde Bednarik
• Sara Kim
• Kamakshi Rao
• Katie Culos
• Kelly Carlstrom
• Colleen Timlin
• Terri Davidson, Syntaxx

Comm, CE Provider, non‐ voting

ASBMT Pharmacy SIG Working Committees 2014‐2015

Advocacy and Policy

• Tippu Khan, Chair
• Jeffrey Betcher, Chair‐Elect
• Susannah Koontz, Past

Chair

• Beth Eddy
• Ila Saunders
• Rebecca Tombleson
• Amy Wiglesworth Bryk

Communications/Website

• Angela Hseih, Chair
• Zahra Mahmoudjafari, Chair
• Ashley Newland, Chair‐Elect
• Meredith Moorman, Past

Chair

• Bill O’Hara, Past Chair
• Teresa Kam
• Sarah Hopps
• Adam Melaragno
• Cathryn Jennisen
• Scott Lanum
• Jim Hart

1/21/2015 12 ASBMT Pharmacy SIG Working Committees 2014‐2015

Education

• Missy Stricherz, Chair
• Michael Westmoreland,

Past‐ Chair

• Valkal Bhatt
• Leanne Kennedy
• Alex Ganetsky
• Amanda Peffer
• Leigh Casey
• Ashley Engemann
• Kelly Valla

Membership

• Amber Clemmons, Chair
• Leanne Kennedy, Chair‐Elect
• Ryan Bookout, Past Chair
• Ryan Shaw
• Zahra Mahmoudjafari
• Jason Yeh
• Maurice Alexander

ASBMT Pharmacy SIG Working Committees

Research

• Steve Stricker, Chair
• Alex Ganetsky, Chair‐Elect
• Joseph Bubalo, Past‐ Chair
• Felicity Wright
• May Aziz
• Sean DeFrates
• Don Hutcherson
• Jeanne McCarthy‐Kaiser
• Christine Walko